Yong-Jun Kwon

He has considerable experience in managing a drug discovery laboratory with core expertise in early discovery and project initiation, including target ID/validation, in vitro/cell-based assay development, HTS/HCS, and hit-to-lead processes, and extensive knowledge in developing cell-based assay and disease model validation with cell line, IPSC derived cell line as well as biopsies from the patient. To date, he has published 28 peer-reviewed scientific papers and has been awarded several international and domestic research grants.